Abiomed (ABMD - Get Report) is a provider of medical devices in circulatory support and offers a continuum of care in heart recovery to acute heart failure patients. This stock is trading up 3.5% to $21.33 in recent trading after hitting a 52-week high of $21.50 earlier in the day.
Today's Range: $20.84-$21.5052-Week Range: $8.97-$21.50 Volume: 153,000 Three-Month Average Volume: 265,486 Abiomed has a market cap of $804 million and an enterprise value of $715 million. This stock trades at a forward price-to-earnings of 125.76. Its estimated growth rate for this year is 78.1%, and for next year it's pegged at 342.9%. The current short interest as a percentage of the float for Abiomed is 6.7%. From a technical standpoint, ABMD has recently triggered a big breakout trade once the stock cleared some past overhead resistance level at $20. >>5 Stocks Setting Up to Break Out Market players should watch for ABMD to continue its trend higher since the stock has held above that key breakout level for a number of trading sessions. As long as ABMD stays above $20 and volume patterns remain decent to strong, then this stock should have a date with $25 in the near future.